Basecamp Wealth Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482 Sell
100
-89
-47% -$537 ﹤0.01% 1640
2026
Q1
$1.16K Buy
189
+156
+473% +$1.29K ﹤0.01% 1517
2025
Q4
$344 Buy
+33
New +$331 ﹤0.01% 1675

Other funds holding RXST

Basecamp Wealth Advisors's RXST Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its RxSight (RXST) stake by 47% in Q2 2026, selling an estimated $537 and leaving 100 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Basecamp Wealth Advisors first reported a position in RXST in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.16K in Q1 2026. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Basecamp Wealth Advisors held 100 shares of RxSight worth $482 as of Q2 2026.
  • Basecamp Wealth Advisors sold 89 RxSight shares in Q2 2026, an estimated $537.
  • RxSight made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1640 holding.
  • Basecamp Wealth Advisors first reported a position in RxSight in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's RxSight position peaked at $1.16K in Q1 2026.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.